Skip to main content
ENPLUS CO., LTD logo

ENPLUS CO., LTD — Investor Relations & Filings

Ticker · 074610 ISIN · KR7074610007 KO Manufacturing
Filings indexed 619 across all filing types
Latest filing 2020-03-20 Audit Report / Informat…
Country KR South Korea
Listing KO 074610

About ENPLUS CO., LTD

https://www.en3.co.kr/en/main

ENPLUS CO., LTD. operates across two main business segments: special vehicles and advanced materials. The company has a long-standing history in manufacturing specialized vehicles, including fire engines and other custom-built environmental vehicles, based on over five decades of accumulated engineering technology. More recently, ENPLUS has expanded its focus to the advanced materials sector, positioning itself as an innovative contract manufacturer for the secondary battery market. This division develops and produces critical components such as electrodes (cathodes and anodes) and thermal interface materials. These materials are primarily supplied to the eco-friendly technology sector for applications in electric vehicles (EVs) and energy storage systems (ESS).

Recent filings

Filing Released Lang Actions
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure of 'Changes in Sales or Profit/Loss Structure of 30% or more'. It provides updated financial figures following an external audit. Since this is a specific regulatory disclosure regarding financial performance updates rather than a full annual report or a simple announcement of a report's availability, it falls under the 'Regulatory Filings' category as a standard corporate disclosure. FY 2019
2020-03-20 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a 'General Meeting of Shareholders' (주주총회소집결의) for NanoMedics. It details the agenda, including financial statement approval, board member appointments, and business purpose changes. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2020-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for NanoMedics. It contains the meeting agenda, date, location, and management information, including details on director activities and business outlook. This is a standard proxy statement/notice of meeting document provided to shareholders to inform them of the upcoming AGM and request their participation/voting.
2020-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유) filed by NanoMedics Co., Ltd. for its 17th Annual General Meeting. It contains detailed information regarding the meeting agenda, including the approval of financial statements, and provides the company's financial statements (balance sheet, income statement, cash flow, etc.) as reference materials for shareholders to exercise their voting rights. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2020-03-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically crossing the 5% threshold or subsequent changes) by a major shareholder and their special related parties. This falls under the 'Major Shareholding Notification' category.
2020-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including the number of shares held, the purpose of holding (management participation), and specific transaction details (buy/sell). This corresponds to the 'Major Shareholding Notification' category.
2020-03-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.